Halozyme Therapeutics Shares Surged: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Halozyme Therapeutics (Nasdaq: HALO  ) are surging by as much as 22.5% today on news that, together with partner Roche Holding, the company has reported positive results from a trial study regarding one of its drugs.

So what: The drug, Herceptin, treats breast cancer and promises to offer a more convenient and faster administration. The phase 3 trial showed that women with early-stage breast cancer that received the new subcutaneous injection showed comparable results to those who received intravenous treatments.

Now what: Administering the drug via subcutaneous methods only takes five minutes compared to the intravenous route, which can take roughly 30 minutes. It also requires no medicine preparation time so it can reduce pharmacy time. Halozyme CEO Dr. Gregory Frost said, "The convenience of subcutaneous administration may provide another option for women living with early breast cancer." As a result, JPM Securities also upgraded the stock to outperform with a $9 price target.

Interested in more info on Halozyme Therapeutics? Add it to your watchlist by clicking here.

Fool contributor Evan Niu holds no position in any company mentioned. Click here to see his holdings and a short bio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1571985, ~/Articles/ArticleHandler.aspx, 12/21/2014 1:41:55 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement